Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Alpine Immune Sciences Inc. (ALPN)

8.79   0.17 (1.97%) 10-01 08:32
Open: 8.61 Pre. Close: 8.62
High: 8.8 Low: 8.32
Volume: 31,319 Market Cap: 209M
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company. The company is headquartered in Seattle, Washington and currently employs 48 full-time employees. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a process known as directed evolution. The vlgD platform exploits both known and unknown interactions at immune synapse through a process called direct evolution for patients living with cancer, autominnue/inflammatory conditions and chronic infectious disease. The company optimizes native immune system proteins for use as therapeutics. The firm also developed Transmembrane Immunomodulatory Protien (TIP) technology, based on the vIgD platform, to enhance engineered cellular therapies. TIP program is created to help companies focused on engineered cellular therapies.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.801 - 8.832 8.832 - 8.86
Low: 8.234 - 8.273 8.273 - 8.308
Close: 8.727 - 8.782 8.782 - 8.833

Technical analysis

as of: 2020-09-30 4:38:31 PM
Overall:       
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 11.29     One year: 13.19
Support: Support1: 7.81    Support2: 6.66
Resistance: Resistance1: 9.67    Resistance2: 11.29
Pivot: 8.11
Moving Average: MA(5): 8.30     MA(20): 7.92
MA(100): 7.77     MA(250): 4.96
MACD: MACD(12,26): -0.06     Signal(9): -0.21
Stochastic oscillator: %K(14,3): 65.56     %D(3): 58.70
RSI: RSI(14): 56.69
52-week: High: 15.00  Low: 2.05  Change(%): 165.6
Average Vol(K): 3-Month: 8041  10-Days: 5318

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ALPN has closed below upper band by 8.2%. Bollinger Bands are 47.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALPN's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 15 Sep 2020
Alpine Immune Sciences to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Yahoo Finance

Tue, 11 Aug 2020
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Fri, 24 Jul 2020
Alpine Immune Sciences Announces $60 Million Private Placement - BioSpace

Wed, 22 Jul 2020
Is Alpine Immune Sciences’ (NASDAQ:ALPN) 126% Share Price Increase Well Justified? - Simply Wall St

Wed, 08 Jul 2020
Alpine Immune Sciences, Inc. (ALPN) Shares March Higher, Can It Continue? - Yahoo Finance

Wed, 24 Jun 2020
Alpine Immune Sciences Announces First Patient Dosed in NEON-1 Phase 1 Trial of ALPN-202 in Patients with Advanced Malignancies - Business Wire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 24
Shares Float (M) 9
% Held by Insiders 40.52
% Held by Institutions 44.39
Shares Short (K) 7
Shares Short P. Month (K) 15

Stock Financials

EPS -1.780
EPS Est This Year -3.180
EPS Est Next Year -2.500
Book Value (p.s.) 0.870
Profit Margin
Operating Margin -1153.25
Return on Assets (ttm) -24.6
Return on Equity (ttm) -107.3
Qtrly Rev. Growth 21.3
Gross Profit (p.s.) -1.434
Sales Per Share 0.124
EBITDA (p.s.) -1.410
Qtrly Earnings Growth
Operating Cash Flow (M) 29
Levered Free Cash Flow (M) 1

Stock Valuations

PE Ratio -4.94
PEG Ratio
Price to Book value 10.10
Price to Sales 70.86
Price to Cash Flow 7.31

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.